Ihn Suk Lee Selected Research

ErbB Receptors (EGF Receptor)

1/2013

Novel ERBB receptor feedback inhibitor 1 (ERRFI1) + 808 T/G polymorphism confers protective effect on diabetic nephropathy in a Korean population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ihn Suk Lee Research Topics

Disease

1	Insulin Resistance 05/2016
1	Body Weight (Weight, Body) 05/2016
1	Obesity 05/2016
1	Thyroiditis 03/2016
1	Cushing Syndrome 01/2016
1	Papillary Thyroid Cancer 01/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2013
1	Hyperaldosteronism (Conn Syndrome) 09/2010
1	Glucocorticoid-Remediable Aldosteronism 09/2010

Drug/Important Bio-Agent (IBA)

1	MicroRNAs (MicroRNA)IBA 05/2016
1	Exenatide (Byetta)FDA Link 05/2016
1	Biomarkers (Surrogate Marker)IBA 05/2016
1	Immunoglobulins (Immunoglobulin)IBA 03/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016
1	CreatinineIBA 01/2016
1	IodineIBA 01/2015
1	Thyroglobulin FDA Link 01/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2013
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 09/2010
1	ReninIBA 09/2010
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 09/2010
1	AldosteroneIBA 09/2010

Therapy/Procedure

2	Thyroidectomy 03/2016 - 01/2015
1	Therapeutics 01/2015